Innovent Biologics (HK:1801) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Innovent Biologics, a biopharmaceutical company, has announced changes to its board committees, effective August 30, 2024. Dr. De-Chao Michael Yu has transitioned from chairman to member of the Nomination Committee, stepping down from the Remuneration Committee. Mr. Shuyun Chen moves from member to chairman of the Nomination Committee and joins the Audit Committee.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
